X-TROZINE L.A. Drug Patent Profile
✉ Email this page to a colleague
Which patents cover X-trozine L.a., and what generic alternatives are available?
X-trozine L.a. is a drug marketed by Shire Richwood and is included in one NDA.
The generic ingredient in X-TROZINE L.A. is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for X-trozine L.a.
A generic version of X-TROZINE L.A. was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for X-TROZINE L.A.?
- What are the global sales for X-TROZINE L.A.?
- What is Average Wholesale Price for X-TROZINE L.A.?
Summary for X-TROZINE L.A.
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 1,902 |
| DailyMed Link: | X-TROZINE L.A. at DailyMed |
US Patents and Regulatory Information for X-TROZINE L.A.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire Richwood | X-TROZINE L.A. | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 087371-001 | Aug 24, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
